Site Editor

Karl D. Lewis, MD

Advertisement

Advertisement

News

Checking Checkpoint Inhibitor Effectiveness in Immunocompromised Patients With Advanced Skin Cancer

Medical Literature

Skin Cancer Awareness Amid the Coronavirus Pandemic: Focus on Internet Searches

News

Trends in Skin Cancers: Findings From Global Burden of Disease Study

News

Serial Excision: Appropriate Alternative to Mohs Micrographic Surgery for Non-Melanoma Skin Cancer?

News

Trends in Skin Cancers: Findings From Global Burden of Disease Study

Medical Literature

Risk Factors by Skin Cancer Type Among Recipients of Organ Transplants

Medical Literature

Skin Cancer Awareness Amid the Coronavirus Pandemic: Focus on Internet Searches

Nikolaos Andreatos, MD, on Adverse Events Following Radiotherapy and Immunotherapy in Patients With Melanoma and Merkel Cell Carcinoma

Michael K.K. Wong, MD, PhD, on KRT-232: First-in-Class Agent for Merkel Cell Carcinoma

View More

Advertisement

JNCCN Spotlights

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

View More

More

News

FDA Expands Pembrolizumab Label for Locally Advanced Cutaneous Squamous Cell Carcinoma

ASCO 2021: Combination of HDAC Inhibitor and Pembrolizumab in Advanced Skin Cancer

Trends in Skin Cancers: Findings From Global Burden of Disease Study

Let There Be Light: Can Blue Light Exposure With Cisplatin Treat Skin Cancer?

Perioperative Use of Cemiplimab Under Study in Cutaneous Squamous Cell Carcinoma

Do Local Excision Margins Influence Survival in Merkel Cell Carcinoma?

AACR 2021: Do Immune-Mediated Diseases Influence Risk of Skin Cancer?

Exploring the Potential Role of Podoplanin in Cutaneous Squamous Cell Carcinoma

View More

Advertisement

Published

Medical Literature

Merkel Cell Carcinoma: Do Women Have Better Outcomes Than Men?

Biopsy Versus Reflectance Confocal Microscopy in Diagnosis of Basal Cell Carcinoma

Long-Term Outcomes in Surgically Managed Skin Cancer in Transplant Recipients

Skin Cancer in Recipients of Liver and Kidney Transplants: Calcineurin Versus mTOR Inhibitors

View More

Ongoing

CE Activities

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

Dana-Farber Cancer Institute

Duke Cancer Institute

View More

Resources

For Your Patients

American Academy of Dermatology

CancerCare

The Skin Cancer Foundation

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.